Sanders Morris Harris’s P3 Health Partners PIII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,690
Closed -$33.9K 267
2025
Q1
$33.9K Hold
3,690
0.01% 276
2024
Q4
$41.5K Buy
3,690
+1,230
+50% +$18.2K 0.01% 279
2024
Q3
$47.5K Sell
2,460
-400
-14% -$10.5K 0.01% 272
2024
Q2
$64.4K Buy
2,860
+400
+16% +$11.9K 0.01% 270
2024
Q1
$127K Hold
2,460
0.02% 246
2023
Q4
$168K Hold
2,460
0.08% 158
2023
Q3
$212K Hold
2,460
0.04% 228
2023
Q2
$368K Buy
+2,460
New +$340K 0.08% 170
2023
Q1
Sell
-2,460
Closed -$226K 223
2022
Q4
$226K Hold
2,460
0.09% 175
2022
Q3
$599K Hold
2,460
0.15% 112
2022
Q2
$465K Hold
2,460
0.1% 158
2022
Q1
$962K Hold
2,460
0.19% 89
2021
Q4
$787K Sell
2,460
-340
-12% -$162K 0.14% 113
2021
Q3
$1.39M Hold
2,800
0.25% 65
2021
Q2
$1.39M Buy
+2,800
New +$1.37M 0.27% 74

Other funds holding PIII

Sanders Morris Harris's PIII Position: Q2 2025 in Review

Sanders Morris Harris sold out of P3 Health Partners (PIII) in Q2 2025, closing a stake of 3,690 shares — an estimated $33.9K sold.

Sanders Morris Harris first reported a position in PIII in Q2 2021 and held it in 15 quarters. The position peaked at $1.39M in Q3 2021. 16 funds tracked by Wall St. Rank hold PIII as of Q2 2025.

  • Sanders Morris Harris reported no remaining P3 Health Partners position as of Q2 2025 after selling out during the quarter.
  • Sanders Morris Harris sold 3,690 P3 Health Partners shares in Q2 2025, an estimated $33.9K.
  • Sanders Morris Harris first reported a position in P3 Health Partners in Q2 2021 and held it in 15 quarters.
  • Sanders Morris Harris's P3 Health Partners position peaked at $1.39M in Q3 2021.
  • 16 funds tracked by Wall St. Rank held P3 Health Partners as of Q2 2025.

Based on Sanders Morris Harris's 13F filing for Q2 2025, filed 30 Jul 2025.